Found: 6
Select item for more details and to access through your institution.
Tirzepatide for the treatment of adults with type 2 diabetes: An endocrine perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 3, doi. 10.1111/dom.14831
- By:
- Publication type:
- Article
Delayed reinnervation by nonpeptidergic nociceptive afferents of the glabrous skin of the rat hindpaw in a neuropathic pain model.
- Published in:
- Journal of Comparative Neurology, 2011, v. 519, n. 1, p. 49, doi. 10.1002/cne.22500
- By:
- Publication type:
- Article
Neurotrophic factor changes in the rat thick skin following chronic constriction injury of the sciatic nerve.
- Published in:
- Molecular Pain, 2012, v. 8, n. 1, p. 1, doi. 10.1186/1744-8069-8-1
- By:
- Publication type:
- Article
Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 10, p. 2783, doi. 10.1007/s13300-021-01140-9
- By:
- Publication type:
- Article
680-P: Once-Weekly Dulaglutide 3 mg and 4.5 mg Gastrointestinal Tolerability: Post-hoc Analysis of Incidence and Prevalence in Award-11.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-680-P
- By:
- Publication type:
- Article
649-P: Impact of Early Initiation of Dulaglutide on A1C in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-649-P
- By:
- Publication type:
- Article